Cited by 34Cell Adhesion Molecules ResearchCancer, Hypoxia, and MetabolismInflammation biomarkers and pathways

Identification of Purα as a New Hypoxia Response Factor Responsible for Coordinated Induction of the β2 Integrin Family

Open access
Kong, Tianqing, Scully, Melanie, Shelley, C Simon, Colgan, Sean P·2007·The Journal of Immunology

Abstract

Central to the process of inflammation are hypoxic conditions that lead to the binding of circulating leukocytes to the endothelium. We have previously shown that such binding is mediated by monocytes being able to directly sense hypoxic conditions and respond by inducing their surface expression of the β2 integrin family of adhesion molecules. In this study, we show that coordinated induction of the β2 integrins during direct hypoxia-sensing occurs through transcriptional activation of each of the genes by which they are encoded. Certain of the molecular mechanisms that mediate this activation in transcription are dependent upon hypoxia-inducible factor-1 (HIF-1), whereas others are HIF-1 independent. In search of these HIF-1-independent mechanisms, we identified Purα as a new hypoxia-response factor. Binding of Purα to the HIF-1-independent β2 integrin promoters is induced by hypoxia and mutagenesis of these Purα-binding sites almost completely abolishes the ability of the promoters to respond to hypoxic conditions. Additional studies using siRNA directed against Purα also revealed a loss in the hypoxic response of the β2 integrin promoters. Taken together, our findings demonstrate that hypoxia induces a coordinated up-regulation in β2 integrin expression that is dependent upon transcriptional mechanisms mediated by HIF-1 and Purα.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.179.3.1934

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HIF-1α transcriptionally controls the β2 integrin (CD18), important in all myeloid cell adhesion and transmigration.

    “Finally, compelling evidence have revealed that HIF-1α transcriptionally controls the critical integrin important in all myeloid cell adhesion and transmigration, namely the β2 integrin (CD18)34,35.”

    From Hypoxia: an alarm signal during intestinal inflammation (2010) · cites this paper as [35]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 47 · Cited by 34

Research works printed but not linked: 1

  1. Shelley, C. S., E. P. Bottinger, and M. A. Aranaout. 1992. Transcriptional Reg- ulation of ␤ 2 Integrins. Elsevier Sciences Publishers, Amsterdam.

Authors
Kong, T., Scully, M., Shelley, C. S., & Colgan, S. P.
Affiliations
  • Brigham and Women's Hospital (US)
  • University of Colorado Health (US)
  • Harvard University (US)
Corresponding author
Kong, Tianqing
Venue
The Journal of Immunology
Published
2007-08-01
Volume
179
Issue
3
Pages
1934-1941
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2155292937
Cited by
34
References
47
Citations by year
2023: 2 · 2020: 2 · 2018: 1 · 2017: 4 · 2016: 5 · 2015: 1 · 2014: 1 · 2013: 7 · 2012: 1
FWCI
2.01
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL060569, HL-60569)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-50189)
  • National Institute of Dental and Craniofacial Research (P50DE016191, DE 016191)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Keywords
Purα, beta2 integrins, HIF-1, transcriptional activation, monocytes, leukocyte-endothelial adhesion, inflammation, hypoxia sensing, promoter binding sites, siRNA knockdown
MeSH terms
Hypoxia, Cell Adhesion, Cells, Cultured, DNA-Binding Proteins, Endothelium, Vascular, Multigene Family, Humans, Leukocytes, Membrane Proteins, Promoter Regions, Genetic, Protein Binding, RNA, Messenger, Transcription Factors, Up-Regulation, CD18 Antigens, CD11 Antigens, U937 Cells, CD11b Antigen, CD11c Antigen, Hypoxia-Inducible Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review